Multiple sclerosis risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(13 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Template:Multiple sclerosis}}
{{Template:Multiple sclerosis}}
{{CMG}}
{{CMG}}; {{AE}}{{Fs}},
Please help WikiDoc by adding content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing.


==Overview==
==Overview==
Common [[risk factors]] in the development of multiple sclerosis are [[smoking]], [[genetic]], [[Ethnic group|ethnic]], [[infection]], low [[vitamin D]], and [[stress]]. Less common [[risk factor]]<nowiki/>s in the development of multiple sclerosis include African Americans, Mexicans, Japanese, Chinese and Filipinos race and [[Epstein Barr virus|Epstein-Barr virus]].


==Risk Factors==
==Risk Factors==
Common environmental risk factors in the development of multiple sclerosis are smoking<ref name="pmid14581676">{{cite journal |vauthors=Riise T, Nortvedt MW, Ascherio A |title=Smoking is a risk factor for multiple sclerosis |journal=Neurology |volume=61 |issue=8 |pages=1122–4 |date=October 2003 |pmid=14581676 |doi= |url=}}</ref>, genetic<ref name="pmid3376997" />, ethnic<ref name="pmid573402" />, infection<ref name="pmid15210894" />, low vitamine D<ref name="pmid12907484" />, occupational exposures and toxins, physical environment and stress.<ref name="pmid14739563">{{cite journal |vauthors=Coo H, Aronson KJ |title=A systematic review of several potential non-genetic risk factors for multiple sclerosis |journal=Neuroepidemiology |volume=23 |issue=1-2 |pages=1–12 |year=2004 |pmid=14739563 |doi=10.1159/000073969 |url=}}</ref>


==== smoking ====
=== Common Risk Factors ===
various studies showed that smoking, beside [[cardiovascular diseases]] and [[cancer]], can be a [[risk factor]] of multiple sclerosis.<ref name="pmid14581676" /><ref name="pmid11427406">{{cite journal |vauthors=Hernán MA, Olek MJ, Ascherio A |title=Cigarette smoking and incidence of multiple sclerosis |journal=Am. J. Epidemiol. |volume=154 |issue=1 |pages=69–74 |date=July 2001 |pmid=11427406 |doi= |url=}}</ref>
* Common [[risk factor]]<nowiki/>s in the development of multiple sclerosis include:
** [[Smoking]]: Various studies show that [[smoking]], beside [[cardiovascular diseases]] and [[cancer]], can be a [[risk factor]] of multiple sclerosis.<ref name="pmid14581676">{{cite journal |vauthors=Riise T, Nortvedt MW, Ascherio A |title=Smoking is a risk factor for multiple sclerosis |journal=Neurology |volume=61 |issue=8 |pages=1122–4 |date=October 2003 |pmid=14581676 |doi= |url=}}</ref><ref name="pmid11427406">{{cite journal |vauthors=Hernán MA, Olek MJ, Ascherio A |title=Cigarette smoking and incidence of multiple sclerosis |journal=Am. J. Epidemiol. |volume=154 |issue=1 |pages=69–74 |date=July 2001 |pmid=11427406 |doi= |url=}}</ref>
** [[Genetic]]: Studies demonstrate that [[MS]] has a strong [[genetic]] base. The first degree family of a [[MS]] patient is at a 10-25 times greater risk than normal population, so genetically susceptible people are more likely to develop [[MS]] disease.<ref name="pmid8800940">{{cite journal |vauthors=Robertson NP, Fraser M, Deans J, Clayton D, Walker N, Compston DA |title=Age-adjusted recurrence risks for relatives of patients with multiple sclerosis |journal=Brain |volume=119 ( Pt 2) |issue= |pages=449–55 |date=April 1996 |pmid=8800940 |doi= |url=}}</ref><ref name="pmid3376997">{{cite journal |vauthors=Sadovnick AD, Baird PA, Ward RH |title=Multiple sclerosis: updated risks for relatives |journal=Am. J. Med. Genet. |volume=29 |issue=3 |pages=533–41 |date=March 1988 |pmid=3376997 |doi=10.1002/ajmg.1320290310 |url=}}</ref>
** Gender: Prevalence of [[MS]] disease is higher in [[female]]. This can be [[hormone]] related or more susceptibility to environmental [[risk factor]]<nowiki/>s.<ref name="pmid17052660">{{cite journal |vauthors=Orton SM, Herrera BM, Yee IM, Valdar W, Ramagopalan SV, Sadovnick AD, Ebers GC |title=Sex ratio of multiple sclerosis in Canada: a longitudinal study |journal=Lancet Neurol |volume=5 |issue=11 |pages=932–6 |date=November 2006 |pmid=17052660 |doi=10.1016/S1474-4422(06)70581-6 |url=}}</ref><ref name="pmid11526384">{{cite journal |vauthors=Whitacre CC |title=Sex differences in autoimmune disease |journal=Nat. Immunol. |volume=2 |issue=9 |pages=777–80 |date=September 2001 |pmid=11526384 |doi=10.1038/ni0901-777 |url=}}</ref>
** [[Vitamin D]]: Low [[vitamin D]] level seems to be a [[risk factor]] for developing [[MS]] since the prevalence of [[MS]] is lower in regions where people take [[vitamin D]] supplement or have higher sunlight exposure.<ref name="pmid12907484">{{cite journal |vauthors=van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Simmons R, Taylor BV, Butzkueven H, Kilpatrick T |title=Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study |journal=BMJ |volume=327 |issue=7410 |pages=316 |date=August 2003 |pmid=12907484 |pmc=169645 |doi=10.1136/bmj.327.7410.316 |url=}}</ref><ref name="pmid14718698">{{cite journal |vauthors=Munger KL, Zhang SM, O'Reilly E, Hernán MA, Olek MJ, Willett WC, Ascherio A |title=Vitamin D intake and incidence of multiple sclerosis |journal=Neurology |volume=62 |issue=1 |pages=60–5 |date=January 2004 |pmid=14718698 |doi= |url=}}</ref>
** [[Stress]]: Stressful life events can be a risk factor for [[MS]] disease. In patients who already have [[MS]], [[stress]] and [[anxiety]] can lead to exacerbation of their disease.<ref name="pmid14739563">{{cite journal |vauthors=Coo H, Aronson KJ |title=A systematic review of several potential non-genetic risk factors for multiple sclerosis |journal=Neuroepidemiology |volume=23 |issue=1-2 |pages=1–12 |year=2004 |pmid=14739563 |doi=10.1159/000073969 |url=}}</ref><ref name="pmid10371517">{{cite journal |vauthors=Goodin DS, Ebers GC, Johnson KP, Rodriguez M, Sibley WA, Wolinsky JS |title=The relationship of MS to physical trauma and psychological stress: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology |journal=Neurology |volume=52 |issue=9 |pages=1737–45 |date=June 1999 |pmid=10371517 |doi= |url=}}</ref>


==== Genetic ====
=== Less Common Risk Factors ===
Some studies demonstrate that [[MS]] has a strong genetic base. The first degree family of a [[MS]] patient is at 10-25 times greater risk than normal population, so genetically susceptible people are more likely to developed [[MS]] disease.<ref name="pmid8800940">{{cite journal |vauthors=Robertson NP, Fraser M, Deans J, Clayton D, Walker N, Compston DA |title=Age-adjusted recurrence risks for relatives of patients with multiple sclerosis |journal=Brain |volume=119 ( Pt 2) |issue= |pages=449–55 |date=April 1996 |pmid=8800940 |doi= |url=}}</ref><ref name="pmid3376997">{{cite journal |vauthors=Sadovnick AD, Baird PA, Ward RH |title=Multiple sclerosis: updated risks for relatives |journal=Am. J. Med. Genet. |volume=29 |issue=3 |pages=533–41 |date=March 1988 |pmid=3376997 |doi=10.1002/ajmg.1320290310 |url=}}</ref>
* Less common [[Risk factors for coronary heart disease|risk factor]]<nowiki/>s in the development of multiple sclerosis include:
 
** Ethnic: MS [[prevalence]] is lower in African Americans, Mexicans, Japanese, Chinese and Filipinos people rather than white men.<ref name="pmid573402">{{cite journal |vauthors=Kurtzke JF, Beebe GW, Norman JE |title=Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution |journal=Neurology |volume=29 |issue=9 Pt 1 |pages=1228–35 |date=September 1979 |pmid=573402 |doi= |url=}}</ref>
==== ethnic ====
** Epstein-Barr virus: [[Patient|Patients]] affected with [[Epstein Barr virus|Epstein-Barr virus]] seems to be more susceptible to developing [[MS]]. Studies shows that high titre of [[Epstein Barr virus|EBV]] [[Antibody|antibodies]] is a [[risk factor]] for [[MS]] disease.<ref name="pmid15210894">{{cite journal |vauthors=Sundström P, Juto P, Wadell G, Hallmans G, Svenningsson A, Nyström L, Dillner J, Forsgren L |title=An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study |journal=Neurology |volume=62 |issue=12 |pages=2277–82 |date=June 2004 |pmid=15210894 |doi= |url=}}</ref><ref name="pmid15914750">{{cite journal |vauthors=Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A |title=Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis |journal=JAMA |volume=293 |issue=20 |pages=2496–500 |date=May 2005 |pmid=15914750 |doi=10.1001/jama.293.20.2496 |url=}}</ref>
[[MS]] prevalence is lower in African Americans, Mexicans, Japanese, Chinese and Filipinos people rather than white men.<ref name="pmid573402">{{cite journal |vauthors=Kurtzke JF, Beebe GW, Norman JE |title=Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution |journal=Neurology |volume=29 |issue=9 Pt 1 |pages=1228–35 |date=September 1979 |pmid=573402 |doi= |url=}}</ref>
 
==== sex ====
Prevalence of [[MS]] disease is higher in female. This can be [[hormone]] related or more susceptibility to environmental risk factors.<ref name="pmid17052660">{{cite journal |vauthors=Orton SM, Herrera BM, Yee IM, Valdar W, Ramagopalan SV, Sadovnick AD, Ebers GC |title=Sex ratio of multiple sclerosis in Canada: a longitudinal study |journal=Lancet Neurol |volume=5 |issue=11 |pages=932–6 |date=November 2006 |pmid=17052660 |doi=10.1016/S1474-4422(06)70581-6 |url=}}</ref><ref name="pmid11526384">{{cite journal |vauthors=Whitacre CC |title=Sex differences in autoimmune disease |journal=Nat. Immunol. |volume=2 |issue=9 |pages=777–80 |date=September 2001 |pmid=11526384 |doi=10.1038/ni0901-777 |url=}}</ref>
 
==== Epstein-Barr virus ====
[[Patient|Patients]] affected with [[Epstein Barr virus|Epstein-Barr virus]] seems to be more susceptible to developing [[MS]]. Studies shows that high titer of [[Epstein Barr virus|EBV]] [[Antibody|antibodies]] is a risk factor for [[MS]] disease.<ref name="pmid15210894">{{cite journal |vauthors=Sundström P, Juto P, Wadell G, Hallmans G, Svenningsson A, Nyström L, Dillner J, Forsgren L |title=An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study |journal=Neurology |volume=62 |issue=12 |pages=2277–82 |date=June 2004 |pmid=15210894 |doi= |url=}}</ref><ref name="pmid15914750">{{cite journal |vauthors=Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A |title=Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis |journal=JAMA |volume=293 |issue=20 |pages=2496–500 |date=May 2005 |pmid=15914750 |doi=10.1001/jama.293.20.2496 |url=}}</ref>
 
==== Vitamin D ====
Low [[vitamin D]] level seems to be a risk factor for developing [[MS]] since the prevalence of [[MS]] is lower in regions where people take [[vitamin D]] supplement or have higher sunlight exposure.<ref name="pmid12907484">{{cite journal |vauthors=van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Simmons R, Taylor BV, Butzkueven H, Kilpatrick T |title=Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study |journal=BMJ |volume=327 |issue=7410 |pages=316 |date=August 2003 |pmid=12907484 |pmc=169645 |doi=10.1136/bmj.327.7410.316 |url=}}</ref><ref name="pmid14718698">{{cite journal |vauthors=Munger KL, Zhang SM, O'Reilly E, Hernán MA, Olek MJ, Willett WC, Ascherio A |title=Vitamin D intake and incidence of multiple sclerosis |journal=Neurology |volume=62 |issue=1 |pages=60–5 |date=January 2004 |pmid=14718698 |doi= |url=}}</ref>


==References==
==References==
{{reflist|2}}
{{reflist|2}}
{{WH}}
{{WS}}


[[Category:Primary care]]
[[Category:Neurology]]
[[Category:Neurology]]
[[Category:Orthopedics]]
[[Category:Orthopedics]]
[[Category:Rheumatology]]
[[Category:Rheumatology]]
{{WH}}
{{WS}}

Latest revision as of 22:48, 29 July 2020

Multiple sclerosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple sclerosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography or Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Alternative Therapies

Primary Prevention

Secondary Prevention

Tertiary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Multiple sclerosis risk factors On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple sclerosis risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple sclerosis risk factors

CDC on Multiple sclerosis risk factors

Multiple sclerosis risk factors in the news

Blogs on Multiple sclerosis risk factors

Directions to Hospitals Treating Multiple sclerosis

Risk calculators and risk factors for Multiple sclerosis risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.,

Overview

Common risk factors in the development of multiple sclerosis are smoking, genetic, ethnic, infection, low vitamin D, and stress. Less common risk factors in the development of multiple sclerosis include African Americans, Mexicans, Japanese, Chinese and Filipinos race and Epstein-Barr virus.

Risk Factors

Common Risk Factors

Less Common Risk Factors

References

  1. Riise T, Nortvedt MW, Ascherio A (October 2003). "Smoking is a risk factor for multiple sclerosis". Neurology. 61 (8): 1122–4. PMID 14581676.
  2. Hernán MA, Olek MJ, Ascherio A (July 2001). "Cigarette smoking and incidence of multiple sclerosis". Am. J. Epidemiol. 154 (1): 69–74. PMID 11427406.
  3. Robertson NP, Fraser M, Deans J, Clayton D, Walker N, Compston DA (April 1996). "Age-adjusted recurrence risks for relatives of patients with multiple sclerosis". Brain. 119 ( Pt 2): 449–55. PMID 8800940.
  4. Sadovnick AD, Baird PA, Ward RH (March 1988). "Multiple sclerosis: updated risks for relatives". Am. J. Med. Genet. 29 (3): 533–41. doi:10.1002/ajmg.1320290310. PMID 3376997.
  5. Orton SM, Herrera BM, Yee IM, Valdar W, Ramagopalan SV, Sadovnick AD, Ebers GC (November 2006). "Sex ratio of multiple sclerosis in Canada: a longitudinal study". Lancet Neurol. 5 (11): 932–6. doi:10.1016/S1474-4422(06)70581-6. PMID 17052660.
  6. Whitacre CC (September 2001). "Sex differences in autoimmune disease". Nat. Immunol. 2 (9): 777–80. doi:10.1038/ni0901-777. PMID 11526384.
  7. van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Simmons R, Taylor BV, Butzkueven H, Kilpatrick T (August 2003). "Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study". BMJ. 327 (7410): 316. doi:10.1136/bmj.327.7410.316. PMC 169645. PMID 12907484.
  8. Munger KL, Zhang SM, O'Reilly E, Hernán MA, Olek MJ, Willett WC, Ascherio A (January 2004). "Vitamin D intake and incidence of multiple sclerosis". Neurology. 62 (1): 60–5. PMID 14718698.
  9. Coo H, Aronson KJ (2004). "A systematic review of several potential non-genetic risk factors for multiple sclerosis". Neuroepidemiology. 23 (1–2): 1–12. doi:10.1159/000073969. PMID 14739563.
  10. Goodin DS, Ebers GC, Johnson KP, Rodriguez M, Sibley WA, Wolinsky JS (June 1999). "The relationship of MS to physical trauma and psychological stress: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology". Neurology. 52 (9): 1737–45. PMID 10371517.
  11. Kurtzke JF, Beebe GW, Norman JE (September 1979). "Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution". Neurology. 29 (9 Pt 1): 1228–35. PMID 573402.
  12. Sundström P, Juto P, Wadell G, Hallmans G, Svenningsson A, Nyström L, Dillner J, Forsgren L (June 2004). "An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study". Neurology. 62 (12): 2277–82. PMID 15210894.
  13. Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A (May 2005). "Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis". JAMA. 293 (20): 2496–500. doi:10.1001/jama.293.20.2496. PMID 15914750.

Template:WH Template:WS